跳转至内容
Merck
  • N-acetyl cysteine improves the effects of corticosteroids in a mouse model of chlorine-induced acute lung injury.

N-acetyl cysteine improves the effects of corticosteroids in a mouse model of chlorine-induced acute lung injury.

Toxicology (2014-12-17)
Elisabeth Wigenstam, Bo Koch, Anders Bucht, Sofia Jonasson
摘要

Chlorine (Cl2) causes tissue damage and a neutrophilic inflammatory response in the airways manifested by pronounced airway hyperreactivity (AHR). The importance of early anti-inflammatory treatment has previously been addressed. In the previous study, both high-dose and low-dose of dexamethasone (DEX) decreased the risk of developing delayed effects, such as persistent lung injuries, while only high-dose treatment could significantly counteract acute-phase effects. One aim of this study was to evaluate whether a low-dose of DEX in combination with the antioxidant N-acetyl cysteine (NAC) and if different treatments (Triptolide, Reparixin and Rolipram) administered 1h after Cl2-exposure could improve protection against acute lung injury in Cl2-exposed mice. BALB/c mice were exposed to 300 ppm Cl2 during 15 min. Assessment of AHR and inflammatory cells in bronchoalveolar lavage was analyzed 24h post exposure. Neither of DEX nor NAC reduced the AHR and displayed only minor effects on inflammatory cell influx when given as separate treatments. When given in combination, a protective effect on AHR and a significant reduction in inflammatory cells (neutrophils) was observed. Neither of triptolide, Reparixin nor Rolipram had an effect on AHR but Triptolide had major effect on the inflammatory cell influx. Treatments did not reduce the concentration of either fibrinogen or plasminogen activator inhibitor-1 in serum, thereby supporting the theory that the inflammatory response is not solely limited to the lung. These results provide a foundation for future studies aimed at identifying new concepts for treatment of chemical-induced lung injury. Studies addressing combination of anti-inflammatory and antioxidant treatment are highly motivated.

材料
货号
品牌
产品描述

Sigma-Aldrich
地塞米松, powder, BioReagent, suitable for cell culture, ≥97%
Sigma-Aldrich
N-乙酰基-L-半胱氨酸, BioReagent, suitable for cell culture
Sigma-Aldrich
地塞米松, ≥98% (HPLC), powder
Sigma-Aldrich
N-乙酰基-L-半胱氨酸, Sigma Grade, ≥99% (TLC), powder
USP
乙酰半胱氨酸, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
雷公藤内酯, from Tripterygium wilfordii, ≥98% (HPLC), solid
Sigma-Aldrich
地塞米松, powder, γ-irradiated, BioXtra, suitable for cell culture, ≥80% (HPLC)
Sigma-Aldrich
地塞米松-21-磷酸二钠盐 二钠盐, ≥98%
USP
地塞米松, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
咯利普兰, solid, ≥98% (HPLC)
Supelco
地塞米松, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
N-乙酰基-L-半胱氨酸, BioXtra, ≥99% (TLC)
Sigma-Aldrich
地塞米松, meets USP testing specifications
Supelco
N-乙酰基-L-半胱氨酸, Pharmaceutical Secondary Standard; Certified Reference Material
地塞米松-21-磷酸二钠盐 二钠盐, European Pharmacopoeia (EP) Reference Standard
地塞米松磷酸钠, European Pharmacopoeia (EP) Reference Standard
乙酰半胱氨酸, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
地塞米松, tested according to Ph. Eur.
地塞米松, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
N-乙酰基-L-半胱氨酸, SAJ special grade, 98.0-102.0%
Supelco
地塞米松, VETRANAL®, analytical standard
地塞米松, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Amyloid Protein Non-Aβ Component, ≥80% (HPLC)
地塞米松, European Pharmacopoeia (EP) Reference Standard
地塞米松, British Pharmacopoeia (BP) Assay Standard